ARTICLE | Clinical News
Enclomiphene citrate regulatory update
November 9, 2015 8:00 AM UTC
FDA cancelled the Nov. 3 meeting of its Bone, Reproductive and Urologic Products Advisory Committee to discuss an NDA from Repros for enclomiphene to treat secondary hypogonadism in overweight men. Re...